Literature DB >> 21672941

Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway.

Li Fu1, Chunyu Zhang, Li-Yi Zhang, Sui-Sui Dong, Lu-Hui Lu, Juan Chen, Yongdong Dai, Yan Li, Kar Lok Kong, Dora L Kwong, Xin-Yuan Guan.   

Abstract

OBJECTIVES: Interaction between neoplastic and stromal cells plays an important role in tumour progression. It was recently found that WNT2 was frequently overexpressed in fibroblasts isolated from tumour tissue tumour fibroblasts (TF) compared with fibroblasts from non-tumour tissue normal fibroblasts in oesophageal squamous cell carcinoma (OSCC). This study aimed to investigate the effect of TF-secreted Wnt2 in OSCC development via the tumour-stroma interaction.
METHODS: Quantitative PCR, western blotting, immunohistochemistry and immunofluorescence were used to study the expression pattern of Wnt2 and its effect on the Wnt/β-catenin pathway. A Wnt2-secreting system was established in Chinese hamster ovary cells and its conditioned medium was used to study the role of Wnt2 in cell proliferation and invasion.
RESULTS: Expression of Wnt2 could only be detected in TF but not in OSCC cancer cell lines. In OSCC tissues, Wnt2(+) cells were mainly detected in the boundary between stroma and tumour tissue or scattered within tumour tissue. In this study, Wnt2-positive OSCC was defined when five or more Wnt2(+) cells were observed in 200× microscopy field. Interestingly, Wnt2-positive OSCC (22/51 cases) was significantly associated with lymph node metastases (p=0.001), advanced TNM stage (p=0.001) and disease-specific survival (p<0.0001). Functional study demonstrated that secreted Wnt2 could promote oesophageal cancer cell growth by activating the Wnt/β-catenin signalling pathway and subsequently upregulated cyclin D1 and c-myc expression. Further study found that Wnt2 could enhance cell motility and invasiveness by inducing epithelial-mesenchymal transition.
CONCLUSIONS: TF-secreted Wnt2 acts as a growth and invasion-promoting factor through activating the canonical Wnt/β-catenin signalling pathway in oesophageal cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672941     DOI: 10.1136/gut.2011.241638

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  57 in total

1.  Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis.

Authors:  Prabukumar Anitha; Ramamurthi Vidya Priyadarsini; Krishnamurthy Kavitha; Paranthaman Thiyagarajan; Siddavaram Nagini
Journal:  Eur J Nutr       Date:  2011-12-11       Impact factor: 5.614

2.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway.

Authors:  Chongbiao Huang; Ruijue Ma; Yong Xu; Na Li; Zengxun Li; Jie Yue; Haixin Li; Yan Guo; Daliang Qi
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.

Authors:  Feiyan Deng; Keming Zhou; Wenli Cui; Dong Liu; Yuqing Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Expression of Gli1 and Wnt2B correlates with progression and clinical outcome of pancreatic cancer.

Authors:  Hua Jiang; Fengru Li; Chengzhi He; Xuebin Wang; Qingqing Li; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia.

Authors:  Zhan Zhang; Lin Zhang; Linlin Zhang; Liting Jia; Peng Wang; Yan Gao
Journal:  Reprod Sci       Date:  2013-01-15       Impact factor: 3.060

Review 7.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 8.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

9.  Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin.

Authors:  Lei Miao; Yuhua Wang; C Michael Lin; Yang Xiong; Naihan Chen; Lu Zhang; William Y Kim; Leaf Huang
Journal:  J Control Release       Date:  2015-08-15       Impact factor: 9.776

Review 10.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.